Although all this growth is encouraging, it is also straining global manufacturing capacities. Biopharma manufacturers are under pressure to find innovative platform technologies to bring products to ...
The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
The intensification of upstream bioprocessing sounds daring, as though it were equivalent to flooring a car’s accelerator pedal and pushing the tachometer into the red zone. But with the right ...